Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
We evaluated the use of Hiltonol® for treating lethal SARS-CoV-infected BALB/c mice. Hiltonol® treatment leads to prophylactic and therapeutic effects. These properties might be therapeutically advantageous.